AstraZeneca Files Litigation Against Salubris About Ticagrelor Tablets--the 350th Issue --- China Intellectual Property

AstraZeneca Files Litigation Against Salubris About Ticagrelor Tablets--the 350th Issue

  Hot Topics
On Jan 16, 2018, AstraZeneca officially filed a litigation to Beijing IP Court against the patent invalid announcement More
 
With the prosperity of art creation and development of artwork trade, it arouse wide attention... More
 
Themed as “Transformation – Reinstalling the IP Value of Enterprises”, The 8th China IP International... More
 
  News in Brief
  China IP Articles
·Challenges and Suggestions on the Application and Protection of IP in the Era of AI
Issue 82, By Wu Xiaolei, Senior Manager of Patent Office, Baidu,[Comprehensive Reports]
It’s not difficult to determine that the era of AI has come. So, perhaps we need to ask: what is AI... More
·Views and Comments on Protection for AI Creations in Copyright Law
Issue 82, By Ke Xuning, Judge at IP Tribunal of Nanjing Municipal Intermediate People’s Court,[Comprehensive Reports]
Due to the technological development, artificial intelligence (AI) has, under the joint action of technologies... More
Forward Subscription  January 19th, 2018
 
   Our Products
Homepage          Cancel Subscription            Contact China IP
 
This Publication is subject to the ownership of China IP. Neither the publication nor any portion hereof may be reprinted, sold or redistributed without written consent of China IP
 

Member Message


Only our members can leave a message,so please register or login.